The frequency of disaster and emergency events continues to rise. Despite this, healthcare staff report a lack of emergency preparedness knowledge and training. Therefore, this study aims to understand the professional backgrounds of students enrolled in healthcare emergency management training, with the goal of highlighting enrollment trends to better utilize resources and expand training opportunities.

Over two thousand data points were retrospectively collected from emergency management course registrations. Occupational backgrounds were categorized for ease of analysis. Test of associations between occupation and course enrollment were based on the chi-square test.

Non-clinical professionals were significantly more likely to be enrolled in emergency management courses than clinical professionals. Of the clinical professionals, nurses represented the highest rates of enrollment, while physicians had the lowest enrollment rates, representing less than 2% of the data set.

This study demonstrates that occupation is correlated to variances in emergency management course enrollment. Additionally, there is a lack of clinical professionals adequately trained in disaster response, especially physicians. Thoughtfully designed emergency management courses tailored to different professional roles could be a key strategy for improving enrollment.

In recent years, government and hospital disaster planners have recognized the increasing importance of pharmaceutical preparedness for chemical, biological, radiological, nuclear, and explosive (CBRNE) events, as well as other public health emergencies. The development of pharmaceutical surge capacity for immediate use before support from the (US) Strategic National Stockpile (SNS) becomes available is integral to strengthening the preparedness of local healthcare networks.

The Pharmaceutical Response Project served as an independent, multidisciplinary collaboration to assess statewide hospital pharmaceutical response capabilities. Surveys of hospital pharmacy directors were conducted to determine pharmaceutical response preparedness to CBRNE threats.

All 45 acute care hospitals in Maryland were surveyed, and responses were collected from 80% (36/45). Ninety-two percent (33/36) of hospitals had assessed pharmaceutical inventory with respect to biological agents, 92% (33/36) for chemical agents, and 67% (24/36) for radiological agents. However, only 64% (23/36) of hospitals reported an additional dedicated reserve supply for biological events, 67% (24/36) for chemical events, and 50% (18/36) for radiological events. More than 60% of the hospitals expected to receive assistance from the SNS within ≤48 hours.

From a pharmaceutical perspective, hospitals generally remain under-prepared for CBRNE threats and many expect SNS support before it realistically would be available. Collectively, limited antibiotics and other supplies are available to offer prophylaxis or treatment, suggesting that hospitals may have insufficient pharmaceutical surge supplies for a large-scale event. Although most state hospitals are improving pharmaceutical surge capabilities, further efforts are needed.